109 related articles for article (PubMed ID: 3213639)
1. The effect of type beta transforming growth factor on proliferation of clonogenic cells from human gliomas.
Helseth E; Unsgaard G; Dalen A; Vik R
Acta Neurochir Suppl (Wien); 1988; 43():118-20. PubMed ID: 3213639
[TBL] [Abstract][Full Text] [Related]
2. The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line.
Helseth E; Unsgaard G; Dalen A; Vik R
J Neurooncol; 1988 Nov; 6(3):269-76. PubMed ID: 3265719
[TBL] [Abstract][Full Text] [Related]
3. Effects of type beta transforming growth factor in combination with retinoic acid or tumor necrosis factor on proliferation of a human glioblastoma cell line and clonogenic cells from freshly resected human brain tumors.
Helseth E; Unsgaard G; Dalen A; Vik R
Cancer Immunol Immunother; 1988; 26(3):273-9. PubMed ID: 3164258
[TBL] [Abstract][Full Text] [Related]
4. Isolation and partial purification of growth factors with TGF-like activity from human malignant gliomas.
Rutka JT; Rosenblum ML; Stern R; Ralston HJ; Dougherty D; Giblin J; DeArmond S
J Neurosurg; 1989 Dec; 71(6):875-83. PubMed ID: 2585080
[TBL] [Abstract][Full Text] [Related]
5. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
Kanno H; Shinonaga M; Kuwabara T; Umeda M
No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
[TBL] [Abstract][Full Text] [Related]
6. TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis.
Jennings MT; Maciunas RJ; Carver R; Bascom CC; Juneau P; Misulis K; Moses HL
Int J Cancer; 1991 Aug; 49(1):129-39. PubMed ID: 1874566
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
8. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
9. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.
Merzak A; McCrea S; Koocheckpour S; Pilkington GJ
Br J Cancer; 1994 Aug; 70(2):199-203. PubMed ID: 8054266
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.
Kuppner MC; Hamou MF; Sawamura Y; Bodmer S; de Tribolet N
J Neurosurg; 1989 Aug; 71(2):211-7. PubMed ID: 2545842
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.
Jennings MT; Hart CE; Commers PA; Whitlock JA; Martincic D; Maciunas RJ; Moots PL; Shehab TM
J Neurooncol; 1997 Feb; 31(3):233-54. PubMed ID: 9049853
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma.
Yamada N; Kato M; Yamashita H; Nistér M; Miyazono K; Heldin CH; Funa K
Int J Cancer; 1995 Aug; 62(4):386-92. PubMed ID: 7635563
[TBL] [Abstract][Full Text] [Related]
14. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
[TBL] [Abstract][Full Text] [Related]
15. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
Yamada Y; Serrero G
J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells.
Jennings JC; Mohan S; Linkhart TA; Widstrom R; Baylink DJ
J Cell Physiol; 1988 Oct; 137(1):167-72. PubMed ID: 3170656
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1.
Hoosein NM; McKnight MK; Levine AE; Mulder KM; Childress KE; Brattain DE; Brattain MG
Exp Cell Res; 1989 Apr; 181(2):442-53. PubMed ID: 2538337
[TBL] [Abstract][Full Text] [Related]
18. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta.
Nugent MA; Lane EA; Keski-Oja J; Moses HL; Newman MJ
Cancer Res; 1989 Jul; 49(14):3884-90. PubMed ID: 2786745
[TBL] [Abstract][Full Text] [Related]
19. Interaction of transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells.
Held-Feindt J; Lütjohann B; Ungefroren H; Mehdorn HM; Mentlein R
J Neurooncol; 2003 Jun; 63(2):117-27. PubMed ID: 12825816
[TBL] [Abstract][Full Text] [Related]
20. TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis.
Jennings MT; Kaariainen IT; Gold L; Maciunas RJ; Commers PA
Hum Pathol; 1994 May; 25(5):464-75. PubMed ID: 8200640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
